Effect of complete epithelial debridement before riboflavin–ultraviolet-A corneal collagen crosslinking therapy
- 1 April 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cataract & Refractive Surgery
- Vol. 34 (4), 657-661
- https://doi.org/10.1016/j.jcrs.2008.02.002
Abstract
PURPOSE: To evaluate the importance of complete epithelial removal before riboflavin–ultraviolet-A (UVA) corneal collagen crosslinking therapy. SETTING: School of Optometry and Vision Sciences, Cardiff University, Wales, United Kingdom. METHODS: Riboflavin eyedrops were applied at 5-minute intervals for 35 minutes to the anterior corneal surface of 36 porcine eyes (12 with no epithelial trauma but treated with tetracaine eyedrops, 12 with superficial epithelial trauma but with an intact basal epithelium, and 12 with a fully removed epithelium). The corneal surface of 6 tetracaine-treated eyes, 6 eyes with superficial epithelial trauma, and 6 eyes with a fully removed epithelium was exposed to UVA light for 30 minutes during riboflavin administration. The light transmission spectra of the enucleated corneas were analyzed with a spectrophotometer and compared with those of 9 untreated porcine corneas. RESULTS: Corneas with a fully removed epithelium treated with riboflavin showed an abnormal dip in the transmission spectrum between 400 nm and 510 nm (P<.01). This was attributed to the presence of riboflavin in the corneal stroma. The spectra of riboflavin-treated corneas with no epithelial trauma but tetracaine administration and those with superficial epithelial trauma did not differ from those of the non–riboflavin-treated controls. Exposure to UVA following riboflavin administration did not alter corneal light transmission. CONCLUSIONS: Complete removal of the corneal epithelium is an essential component of riboflavin–UVA crosslinking therapy as superficial epithelial trauma and tetracaine administration alone are not sufficient to permit the penetration of riboflavin into the corneal stroma. Failure to achieve adequate stromal absorption of riboflavin may impair the efficacy of the crosslinking process.Keywords
This publication has 15 references indexed in Scilit:
- Crosslinking treatment of progressive keratoconus: new hopeCurrent Opinion in Opthalmology, 2006
- Outcomes of Penetrating Keratoplasty in KeratoconusCornea, 2005
- Risk Factors for Progression to Penetrating Keratoplasty in Patients With KeratoconusAmerican Journal of Ophthalmology, 2005
- Penetrating keratoplasty: indications over a 10 year periodBritish Journal of Ophthalmology, 2004
- Thermomechanical Behavior of Collagen-Cross-Linked Porcine CorneaOphthalmologica, 2004
- Increased resistance of crosslinked cornea against enzymatic digestionCurrent Eye Research, 2004
- Stress-strain measurements of human and porcine corneas after riboflavin–ultraviolet-A-induced cross-linkingJournal of Cataract & Refractive Surgery, 2003
- Endothelial cell damage after riboflavin–ultraviolet-A treatment in the rabbitJournal of Cataract & Refractive Surgery, 2003
- Changing Trends in the Indications for Penetrating KeratoplastyAmerican Journal of Ophthalmology, 1992
- Keratoconus and related noninflammatory corneal thinning disordersSurvey of Ophthalmology, 1984